Breast cancer drug approvals
RecordSTO-EVH61V5CNV-GR3ADB2EDG-QSS2AM
China · 2025
Breast cancer drug approvals in China were 9 in 2025 (DIA).
New drug approvals in China: every year, the rank and how it is measured
- Publisher
- DIA
- Authority tier
- T2 Official
- Locator
- The Cancer Sector Continues to Attract the Most Players
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Breast cancer was the most active area with a total of nine new entrants, including the PI3Kα inhibitor inavolisib, the AKT inhibitor capivasertib, the TROP2- and HER2-targeted ADCs datopotamab deruxtecan and trastuzumab botidotin respectively, as well as multiple CDK inhibitors, namely bireociclib, lerociclib, tibremciclib, fovinaciclib, and culmerciclib.
Checked: the figure 9is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_EVH61V5CNVGR3ADB2EDGQSS2AM
Other formats: MLA, Chicago, BibTeX
- MLA
- DIA. "2025 NMPA Approvals: China Clears Record Number of New Drugs." 2025, https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_EVH61V5CNVGR3ADB2EDGQSS2AM.
- Chicago
- DIA. "2025 NMPA Approvals: China Clears Record Number of New Drugs." 2025. https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_EVH61V5CNVGR3ADB2EDGQSS2AM.
- BibTeX
- @misc{dia2025breastqss2am, author = {{DIA}}, title = {2025 NMPA Approvals: China Clears Record Number of New Drugs}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_EVH61V5CNVGR3ADB2EDGQSS2AM}, note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- DIA · homepage ↗
- Authority tier
- Tier 2 · National and industry official
- Report
- 2025 NMPA Approvals: China Clears Record Number of New Drugs
- Type
- Press release
- Published
- —
- Locator
- The Cancer Sector Continues to Attract the Most Players
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_EVH61V5CNVGR3ADB2EDGQSS2AM